Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acquired hypophosphatemia

S F Hodgson1, D L Hurley

  • 1Division of Endocrinology, Metabolism, and Internal Medicine, Mayo Clinic, Rochester, Minnesota.

Endocrinology and Metabolism Clinics of North America
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered growth hormone-releasing hormone mRNA expression in transgenic mice with excess or deficient endogenous growth hormone.

Molecular and cellular neurosciences·2009
Same author

Prolactin induces tuberoinfundibular dopaminergic neurone differentiation in Snell dwarf mice if administered beginning at 3 days of age.

Journal of neuroendocrinology·2009
Same author

Mediastinal parathyroid carcinoma.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2004
Same author

Growth hormone-releasing hormone-producing and dopaminergic neurones in the mouse arcuate nucleus are independently regulated populations.

Journal of neuroendocrinology·2003
Same author

Stronger back muscles reduce the incidence of vertebral fractures: a prospective 10 year follow-up of postmenopausal women.

Bone·2002
Same author

IGF-I causes an ultrasensitive reduction in GH mRNA levels via an extracellular mechanism involving IGF binding proteins.

Molecular endocrinology (Baltimore, Md.)·2001
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

This article explains serum phosphorus regulation and acquired hypophosphatemia, detailing its causes, symptoms, and when it leads to severe illness.

Area of Science:

  • Biochemistry
  • Pathophysiology
  • Clinical Medicine

Background:

  • Serum phosphorus is tightly regulated under normal physiological conditions.
  • Acquired hypophosphatemia is a significant clinical concern with diverse etiologies.
  • Understanding phosphorus homeostasis is crucial for diagnosing and managing related disorders.

Purpose of the Study:

  • To elucidate the mechanisms of serum phosphorus regulation.
  • To describe the pathophysiology and clinical manifestations of acquired hypophosphatemia.
  • To highlight clinical scenarios associated with severe hypophosphatemia-induced morbidity.

Main Methods:

  • Review of existing literature on phosphorus metabolism and hypophosphatemia.
  • Analysis of clinical data pertaining to hypophosphatemia.

Related Experiment Videos

  • Emphasis on pathophysiological pathways and clinical presentations.

    • Main Results:

    • Detailed discussion of the regulatory pathways governing serum phosphorus levels.
    • Comprehensive overview of the pathophysiology of acquired hypophosphatemia.
    • Identification of specific clinical conditions predisposing to severe hypophosphatemia.

    Conclusions:

    • Acquired hypophosphatemia arises from disruptions in normal phosphorus regulation.
    • Clinical manifestations vary, but severe morbidity can occur in specific settings.
    • Further research into prevention and management strategies is warranted.